Nippon India Pharma Fund Regular Growth

Nippon India Pharma Fund Regular Growth: NAV ₹586.27, 3Y return 16.77%, 5Y 14.20%, AUM ₹9,279 Cr, expense ratio 1.84%, iNVESTT rating 4/5. Returns vs index, rolling returns, holdings, Direct vs Regular and peers, by a SEBI Registered Research Analyst.

Key facts

NAV
₹586.2713 (19 Nov 2026)
1-year return
13.08%
3-year return (CAGR)
16.77%
5-year return (CAGR)
14.20%
Fund size (AUM)
₹9,279 Cr
Expense ratio
1.84%
Exit load
1% if redeemed or switched out on or before completion of 1 month from the date of allotment of units.Nil, thereafter.
Minimum investment
Rs. 5,000 and in multiples of Re.1 thereafter
Category
Sectoral Fund
Benchmark
BSE Healthcare TRI
Riskometer
Very High Risk
Fund manager
Sailesh Raj Bhan
Launch date
10 May 2004
iNVESTT rating
4 out of 5

Frequently asked questions

What is the NAV of Nippon India Pharma Fund Regular Growth today?

The NAV of Nippon India Pharma Fund Regular Growth is ₹586.2713 as of 19 Nov 2026.

What are the returns of Nippon India Pharma Fund Regular Growth?

13.08% over 1 year, 16.77% a year over 3 years, 14.20% a year over 5 years. Past returns do not guarantee future returns; compare them with the benchmark and rolling returns on this page.

What is the expense ratio of Nippon India Pharma Fund Regular Growth?

The expense ratio (TER) is 1.84% a year. This Regular plan includes a distributor commission; the Direct plan of the same fund costs less.

What is the AUM (fund size) of Nippon India Pharma Fund Regular Growth?

Nippon India Pharma Fund Regular Growth manages ₹9,279 Cr.

Is there an exit load on Nippon India Pharma Fund Regular Growth?

Exit load: 1% if redeemed or switched out on or before completion of 1 month from the date of allotment of units.Nil, thereafter..

How risky is Nippon India Pharma Fund Regular Growth?

Its SEBI riskometer is "Very High Risk" and it is in the Sectoral Fund category.

What is the benchmark of Nippon India Pharma Fund Regular Growth?

The benchmark is BSE Healthcare TRI. This page compares the fund with its benchmark's total-return index (TRI).

What is the iNVESTT rating of Nippon India Pharma Fund Regular Growth?

4 out of 5. iNVESTT rating: where the fund ranks in its category over 1, 3 and 5 years (3 and 5 years count most). Top fifth = 5 stars. A past-performance measure, not a recommendation.

Research by iNVESTT, a SEBI Registered Research Analyst (INH000010858). Data from AMFI. Mutual fund investments are subject to market risks; past performance does not guarantee future returns.

Mutual fund research · Fund screener · Compare this fund · SIP calculator · Personal advisory